Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma

Keiichiro Watanabe; Ariunzaya Bat-Erdene; Hirofumi Tenshin; Qu Cui; Jumpei Teramachi; Masahiro Hiasa; Asuka Oda; Takeshi Harada; Hirokazu Miki; Kimiko Sogabe; Masahiro Oura; Ryohei Sumitani; Yukari Mitsui; Itsuro Endo; Eiji Tanaka; Makoto Kawatani; Hiroyuki Osada; Toshio Matsumoto; Masahiro Abe

doi:10.3324/haematol.2019.244418

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma

Keiichiro Watanabe, Ariunzaya Bat-Erdene, Hirofumi Tenshin, Qu Cui, Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Takeshi Harada, Hirokazu Miki, Kimiko Sogabe, Masahiro Oura, Ryohei Sumitani, Yukari Mitsui, Itsuro Endo, Eiji Tanaka, Makoto Kawatani, Hiroyuki Osada, Toshio Matsumoto, Masahiro Abe

研究成果 › 査読

3 被引用数 (Scopus)

本文言語	English
ページ（範囲）	1172-1177
ページ数	6
ジャーナル	Haematologica
巻	106
号	4
DOI	https://doi.org/10.3324/haematol.2019.244418
出版ステータス	Published - 4月 2021
外部発表	はい

ASJC Scopus subject areas

血液学

文献へのアクセス

10.3324/haematol.2019.244418

他のファイルとリンク

引用スタイル

Watanabe, K., Bat-Erdene, A., Tenshin, H., Cui, Q., Teramachi, J., Hiasa, M., Oda, A., Harada, T., Miki, H., Sogabe, K., Oura, M., Sumitani, R., Mitsui, Y., Endo, I., Tanaka, E., Kawatani, M., Osada, H., Matsumoto, T., & Abe, M. (2021). Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma. Haematologica, 106(4), 1172-1177. https://doi.org/10.3324/haematol.2019.244418

Watanabe, K, Bat-Erdene, A, Tenshin, H, Cui, Q, Teramachi, J, Hiasa, M, Oda, A, Harada, T, Miki, H, Sogabe, K, Oura, M, Sumitani, R, Mitsui, Y, Endo, I, Tanaka, E, Kawatani, M, Osada, H, Matsumoto, T & Abe, M 2021, 'Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma', Haematologica, vol. 106, no. 4, pp. 1172-1177. https://doi.org/10.3324/haematol.2019.244418

@article{d30ad37501134df89077b635f62852dd,

title = "Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma",

author = "Keiichiro Watanabe and Ariunzaya Bat-Erdene and Hirofumi Tenshin and Qu Cui and Jumpei Teramachi and Masahiro Hiasa and Asuka Oda and Takeshi Harada and Hirokazu Miki and Kimiko Sogabe and Masahiro Oura and Ryohei Sumitani and Yukari Mitsui and Itsuro Endo and Eiji Tanaka and Makoto Kawatani and Hiroyuki Osada and Toshio Matsumoto and Masahiro Abe",

note = "Funding Information: this work was supported in part by JSPS KAKENHI grant ns. JP15K20536, JP16K11504, JP17KK0169, JP17K09956, JP17H05104, JP18K08329, JP18K16118, and JP18H06294, and the Research Clusters program of Tokushima University. The funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript. The authors would like to thank Dr. Toshihiko Nogawa (RIKEN) for preparing reveromycin A. Funding Information: Contributions: KW, AB, HT, MK, HO and MA designed the research and conceived the project. Animal experiments were performed by KW, QC, HT, TH, HM, KS, MO, RS and JT; cell cultures by KW, AB, HT, AO, TH, KS, MO and RS; immunoblotting by AB, JT, HT, AO and MH; and bone analyses by KW, QC, YM, MH, IE, and ET. KW, AB, HT, MK, HO, TM and MA analyzed and discussed the data, and wrote the manuscript. Funding: this work was supported in part by JSPS KAKENHI grant ns. JP15K20536, JP16K11504, JP17KK0169, JP17K09956, JP17H05104, JP18K08329, JP18K16118, and JP18H06294, and the Research Clusters program of Tokushima University. The funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript. The authors would like to thank Dr. Toshihiko Nogawa (RIKEN) for preparing reveromycin A.",

year = "2021",

month = apr,

doi = "10.3324/haematol.2019.244418",

language = "English",

volume = "106",

pages = "1172--1177",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "4",

}

TY - JOUR

T1 - Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma

AU - Watanabe, Keiichiro

AU - Bat-Erdene, Ariunzaya

AU - Tenshin, Hirofumi

AU - Cui, Qu

AU - Teramachi, Jumpei

AU - Hiasa, Masahiro

AU - Oda, Asuka

AU - Harada, Takeshi

AU - Miki, Hirokazu

AU - Sogabe, Kimiko

AU - Oura, Masahiro

AU - Sumitani, Ryohei

AU - Mitsui, Yukari

AU - Endo, Itsuro

AU - Tanaka, Eiji

AU - Kawatani, Makoto

AU - Osada, Hiroyuki

AU - Matsumoto, Toshio

AU - Abe, Masahiro

N1 - Funding Information: this work was supported in part by JSPS KAKENHI grant ns. JP15K20536, JP16K11504, JP17KK0169, JP17K09956, JP17H05104, JP18K08329, JP18K16118, and JP18H06294, and the Research Clusters program of Tokushima University. The funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript. The authors would like to thank Dr. Toshihiko Nogawa (RIKEN) for preparing reveromycin A. Funding Information: Contributions: KW, AB, HT, MK, HO and MA designed the research and conceived the project. Animal experiments were performed by KW, QC, HT, TH, HM, KS, MO, RS and JT; cell cultures by KW, AB, HT, AO, TH, KS, MO and RS; immunoblotting by AB, JT, HT, AO and MH; and bone analyses by KW, QC, YM, MH, IE, and ET. KW, AB, HT, MK, HO, TM and MA analyzed and discussed the data, and wrote the manuscript. Funding: this work was supported in part by JSPS KAKENHI grant ns. JP15K20536, JP16K11504, JP17KK0169, JP17K09956, JP17H05104, JP18K08329, JP18K16118, and JP18H06294, and the Research Clusters program of Tokushima University. The funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript. The authors would like to thank Dr. Toshihiko Nogawa (RIKEN) for preparing reveromycin A.

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85103682696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103682696&partnerID=8YFLogxK

U2 - 10.3324/haematol.2019.244418

DO - 10.3324/haematol.2019.244418

M3 - Letter

C2 - 32586903

AN - SCOPUS:85103682696

SN - 0390-6078

VL - 106

SP - 1172

EP - 1177

JO - Haematologica

JF - Haematologica

IS - 4

ER -